CVL-751-PD-004: 58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)

Grants and Contracts Details

StatusFinished
Effective start/end date12/10/20 → 5/2/23

Funding

  • Syneos Health LLC: $32,107.00